2016
DOI: 10.7554/elife.12187.022
|View full text |Cite
|
Sign up to set email alerts
|

Author response: Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…The apparent absence of a congression defect in Bub1 -/cells is consistent with previous work in RPE1 cells treated with Bub1 kinase inhibitors, but is perhaps surprising given the known role of Bub1 in error correction through the Histone2A-Sgo1/PP2A-Aurora B pathway [7]. We therefore generated multiple malorientated attachments by releasing cells from a nocodazole arrest and measured the time to completion of congression and anaphase onset.…”
Section: Correspondencesupporting
confidence: 84%
See 1 more Smart Citation
“…The apparent absence of a congression defect in Bub1 -/cells is consistent with previous work in RPE1 cells treated with Bub1 kinase inhibitors, but is perhaps surprising given the known role of Bub1 in error correction through the Histone2A-Sgo1/PP2A-Aurora B pathway [7]. We therefore generated multiple malorientated attachments by releasing cells from a nocodazole arrest and measured the time to completion of congression and anaphase onset.…”
Section: Correspondencesupporting
confidence: 84%
“…One possibility is that the KBB and RZZ pathways monitor different attachment states [2]. Furthermore, the contribution of the KBB pathway to SAC signalling and error correction may vary between cell types or state of cellular transformation [2,7]. Future work will be needed to understand the relative roles of KBB and RZZ in these different contexts.…”
Section: Correspondencementioning
confidence: 99%